University of Texas Southwestern Medical Center: Multiple Sclerosis trials

The registry lists 11 Multiple Sclerosis studies with University of Texas Southwestern Medical Center as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 2 3Phase 3 1Phase 4 3No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• NARCOMS Registry: A Multiple Sclerosis RegistryRecruitingNCT01018537
• Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple SclerosisCompletedNCT03135249Phase 4Results posted
• Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)CompletedNCT02739542Phase 4Results posted
• The Effects of Ankle Foot Orthoses (AFOs) on Mobility in Persons With Multiple Sclerosis (MS)CompletedNCT01947582Not applicableResults posted
• Effectiveness of Ankle Foot Orthoses on Gait in Multiple SclerosisTerminatedNCT01796860Not applicableResults posted
• Cladribine Tablets After Treatment With Natalizumab (CLADRINA)Active, not recruitingNCT04178005Phase 4
• PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.CompletedNCT03942952
• Alternative Treatment Paradigm for Natalizumab TrialWithdrawnNCT01710228Phase 2
• Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple SclerosisCompletedNCT00324506Phase 2
• Factors That Influence Compliance With Disease-Modifying Therapy in Multiple SclerosisCompletedNCT00223457
• Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple SclerosisCompletedNCT00223301Phase 2/3